CEREVEL THERAPEUTICS HLDNG I's ticker is and the CUSIP is 15678U958. A total of 5 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $272,875 | -54.6% | 12,500 | -33.9% | 0.00% | -50.0% |
Q2 2023 | $600,831 | +38.4% | 18,900 | +6.2% | 0.00% | 0.0% |
Q1 2023 | $434,142 | -67.8% | 17,800 | -58.3% | 0.00% | -33.3% |
Q4 2022 | $1,346,758 | +875.9% | 42,700 | +771.4% | 0.00% | – |
Q3 2022 | $138,000 | -80.7% | 4,900 | -81.9% | 0.00% | -100.0% |
Q2 2022 | $714,000 | +1357.1% | 27,000 | +1828.6% | 0.00% | – |
Q1 2022 | $49,000 | -93.0% | 1,400 | -93.5% | 0.00% | -100.0% |
Q4 2021 | $704,000 | +65.6% | 21,700 | +50.7% | 0.00% | – |
Q3 2021 | $425,000 | – | 14,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 21,700 | $704,000 | 0.00% |
SIMPLEX TRADING, LLC | 3,000 | $97,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |